{"id":15102,"date":"2022-12-15T10:46:12","date_gmt":"2022-12-15T15:46:12","guid":{"rendered":"https:\/\/innovativemedicines.ca\/newsroom\/all-news\/"},"modified":"2022-12-15T10:47:44","modified_gmt":"2022-12-15T15:47:44","slug":"problemes-lies-presidence-cepmb-accentuent-necessite-suspendre-mise-en-oeuvre-lignes-directrices-provisoires-revisees","status":"publish","type":"news","link":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/problemes-lies-presidence-cepmb-accentuent-necessite-suspendre-mise-en-oeuvre-lignes-directrices-provisoires-revisees\/","title":{"rendered":"Les probl\u00e8mes li\u00e9s \u00e0 la pr\u00e9sidence du CEPMB accentuent la n\u00e9cessit\u00e9 de suspendre la mise en \u0153uvre des Lignes directrices provisoires r\u00e9vis\u00e9es"},"content":{"rendered":"\n<p><strong>Ottawa, Ontario<\/strong>. \u2013 \u00c0 la suite de la d\u00e9mission de la pr\u00e9sidente par int\u00e9rim du Conseil d\u2019examen du prix des m\u00e9dicaments brevet\u00e9s (CEPMB) la semaine derni\u00e8re, M\u00e9dicaments novateurs Canada (MNC) demande la suspension de la mise en \u0153uvre des Lignes directrices provisoires r\u00e9vis\u00e9es du CEPMB afin d\u2019assurer qu\u2019une consultation s\u00e9rieuse des parties prenantes et une analyse approfondie des r\u00e9percussions soient entreprises.<\/p>\n\n\n\n<p>Le Conseil d\u2019administration du CEPMB se retrouve sans pr\u00e9sident depuis novembre 2021. Avec le d\u00e9part r\u00e9cent de la pr\u00e9sidente par int\u00e9rim du CEPMB, on ignore comment ce dernier peut examiner les multiples soumissions, apporter les modifications et les changements \u00e9ventuels, et mettre en \u0153uvre les nouvelles Lignes directrices d\u2019ici janvier 2023.<\/p>\n\n\n\n<p>Compte tenu de l\u2019\u00e9tendue et des cons\u00e9quences des Lignes directrices provisoires r\u00e9vis\u00e9es, MNC estime qu\u2019elles doivent uniquement \u00eatre mises en \u0153uvre par le CEPMB apr\u00e8s qu\u2019il a proc\u00e9d\u00e9 \u00e0 une consultation s\u00e9rieuse des parties prenantes et suivi un processus pangouvernemental qui prend en compte les r\u00e9percussions importantes des changements propos\u00e9s sur la sant\u00e9 et l\u2019\u00e9conomie.<\/p>\n\n\n\n<p>\u00c0 moins d\u2019\u00eatre modifi\u00e9es de fa\u00e7on importante, les Lignes directrices provisoires propos\u00e9es ne feront que r\u00e9duire davantage l\u2019acc\u00e8s aux nouveaux m\u00e9dicaments, traitements et essais cliniques pour les Canadiens, en plus de compromettre le succ\u00e8s d\u2019autres priorit\u00e9s gouvernementales comme la strat\u00e9gie nationale sur les m\u00e9dicaments pour le traitement des maladies rares et la strat\u00e9gie en mati\u00e8re de biofabrication et de sciences de la vie.<\/p>\n\n\n\n<h5 class=\"wp-block-heading\">\u00c0 propos de M\u00e9dicaments novateurs Canada<\/h5>\n\n\n\n<p>M\u00e9dicaments novateurs Canada (MNC) est l\u2019association nationale qui repr\u00e9sente la voix de l\u2019industrie pharmaceutique innovatrice canadienne. L\u2019association d\u00e9fend des politiques qui favorisent la d\u00e9couverte, le d\u00e9veloppement et l\u2019offre de m\u00e9dicaments et de vaccins novateurs afin d\u2019am\u00e9liorer la vie de l\u2019ensemble de la population. De plus, elle soutient l\u2019engagement de ses membres d\u2019\u00eatre des partenaires pr\u00e9cieux du syst\u00e8me de sant\u00e9 canadien. L\u2019association repr\u00e9sente 50 entreprises, qui investissent pr\u00e8s de 1,4 milliard de dollars par an en recherche et d\u00e9veloppement. De cette fa\u00e7on, elle alimente l\u2019\u00e9conomie fond\u00e9e sur la connaissance du pays tout en contribuant \u00e0 hauteur de 8 milliards de dollars \u00e0 l\u2019\u00e9conomie nationale. Tous ses membres suivent le Code d\u2019\u00e9thique de MNC, ils travaillent donc de mani\u00e8re hautement \u00e9thique avec les gouvernements, les payeurs priv\u00e9s, les professionnels de la sant\u00e9 et les parties prenantes.<\/p>\n\n\n\n<p class=\"has-text-align-center\">-30-<\/p>\n\n\n\n<p>Pour de plus amples renseignements :<\/p>\n\n\n\n<p>Marise Varanda<br \/>Directrice, Relations avec les m\u00e9dias et contenu<br \/>T\u00e9l\u00e9phone : 613-462-5367<br \/>Courriel : <a href=\"mailto:media@imc-mnc.ca\">media@imc-mnc.ca<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ottawa, Ontario. \u2013 \u00c0 la suite de la d\u00e9mission de la pr\u00e9sidente par int\u00e9rim du Conseil d\u2019examen du prix des [&hellip;]<\/p>\n","protected":false},"featured_media":15104,"template":"","topic":[245],"team-member-id":[],"news-category":[176],"news-tag":[],"class_list":["post-15102","news","type-news","status-publish","has-post-thumbnail","hentry","topic-conseil-dexamen-du-prix-des-medicaments-brevetes-cepmb","news-category-communique"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Les probl\u00e8mes li\u00e9s \u00e0 la pr\u00e9sidence du CEPMB accentuent la n\u00e9cessit\u00e9 de suspendre la mise en \u0153uvre des Lignes directrices provisoires r\u00e9vis\u00e9es - Innovative Medicines Canada<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/problemes-lies-presidence-cepmb-accentuent-necessite-suspendre-mise-en-oeuvre-lignes-directrices-provisoires-revisees\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Les probl\u00e8mes li\u00e9s \u00e0 la pr\u00e9sidence du CEPMB accentuent la n\u00e9cessit\u00e9 de suspendre la mise en \u0153uvre des Lignes directrices provisoires r\u00e9vis\u00e9es - Innovative Medicines Canada\" \/>\n<meta property=\"og:description\" content=\"Ottawa, Ontario. \u2013 \u00c0 la suite de la d\u00e9mission de la pr\u00e9sidente par int\u00e9rim du Conseil d\u2019examen du prix des [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/problemes-lies-presidence-cepmb-accentuent-necessite-suspendre-mise-en-oeuvre-lignes-directrices-provisoires-revisees\/\" \/>\n<meta property=\"og:site_name\" content=\"Innovative Medicines Canada\" \/>\n<meta property=\"article:modified_time\" content=\"2022-12-15T15:47:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2022\/12\/iStock-108272690-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1980\" \/>\n\t<meta property=\"og:image:height\" content=\"1320\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/problemes-lies-presidence-cepmb-accentuent-necessite-suspendre-mise-en-oeuvre-lignes-directrices-provisoires-revisees\/\",\"url\":\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/problemes-lies-presidence-cepmb-accentuent-necessite-suspendre-mise-en-oeuvre-lignes-directrices-provisoires-revisees\/\",\"name\":\"Les probl\u00e8mes li\u00e9s \u00e0 la pr\u00e9sidence du CEPMB accentuent la n\u00e9cessit\u00e9 de suspendre la mise en \u0153uvre des Lignes directrices provisoires r\u00e9vis\u00e9es - Innovative Medicines Canada\",\"isPartOf\":{\"@id\":\"https:\/\/innovativemedicines.ca\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/problemes-lies-presidence-cepmb-accentuent-necessite-suspendre-mise-en-oeuvre-lignes-directrices-provisoires-revisees\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/problemes-lies-presidence-cepmb-accentuent-necessite-suspendre-mise-en-oeuvre-lignes-directrices-provisoires-revisees\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2022\/12\/iStock-108272690-scaled.jpg\",\"datePublished\":\"2022-12-15T15:46:12+00:00\",\"dateModified\":\"2022-12-15T15:47:44+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/problemes-lies-presidence-cepmb-accentuent-necessite-suspendre-mise-en-oeuvre-lignes-directrices-provisoires-revisees\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/problemes-lies-presidence-cepmb-accentuent-necessite-suspendre-mise-en-oeuvre-lignes-directrices-provisoires-revisees\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/problemes-lies-presidence-cepmb-accentuent-necessite-suspendre-mise-en-oeuvre-lignes-directrices-provisoires-revisees\/#primaryimage\",\"url\":\"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2022\/12\/iStock-108272690-scaled.jpg\",\"contentUrl\":\"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2022\/12\/iStock-108272690-scaled.jpg\",\"width\":1980,\"height\":1320},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/problemes-lies-presidence-cepmb-accentuent-necessite-suspendre-mise-en-oeuvre-lignes-directrices-provisoires-revisees\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/innovativemedicines.ca\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Actualit\u00e9s\",\"item\":\"https:\/\/innovativemedicines.ca\/fr\/actualites\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Actualit\u00e9s\",\"item\":\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Les probl\u00e8mes li\u00e9s \u00e0 la pr\u00e9sidence du CEPMB accentuent la n\u00e9cessit\u00e9 de suspendre la mise en \u0153uvre des Lignes directrices provisoires r\u00e9vis\u00e9es\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/innovativemedicines.ca\/fr\/#website\",\"url\":\"https:\/\/innovativemedicines.ca\/fr\/\",\"name\":\"Innovative Medicines Canada\",\"description\":\"Transforming Canadians\u2019 lives\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/innovativemedicines.ca\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Les probl\u00e8mes li\u00e9s \u00e0 la pr\u00e9sidence du CEPMB accentuent la n\u00e9cessit\u00e9 de suspendre la mise en \u0153uvre des Lignes directrices provisoires r\u00e9vis\u00e9es - Innovative Medicines Canada","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/problemes-lies-presidence-cepmb-accentuent-necessite-suspendre-mise-en-oeuvre-lignes-directrices-provisoires-revisees\/","og_locale":"fr_FR","og_type":"article","og_title":"Les probl\u00e8mes li\u00e9s \u00e0 la pr\u00e9sidence du CEPMB accentuent la n\u00e9cessit\u00e9 de suspendre la mise en \u0153uvre des Lignes directrices provisoires r\u00e9vis\u00e9es - Innovative Medicines Canada","og_description":"Ottawa, Ontario. \u2013 \u00c0 la suite de la d\u00e9mission de la pr\u00e9sidente par int\u00e9rim du Conseil d\u2019examen du prix des [&hellip;]","og_url":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/problemes-lies-presidence-cepmb-accentuent-necessite-suspendre-mise-en-oeuvre-lignes-directrices-provisoires-revisees\/","og_site_name":"Innovative Medicines Canada","article_modified_time":"2022-12-15T15:47:44+00:00","og_image":[{"width":1980,"height":1320,"url":"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2022\/12\/iStock-108272690-scaled.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/problemes-lies-presidence-cepmb-accentuent-necessite-suspendre-mise-en-oeuvre-lignes-directrices-provisoires-revisees\/","url":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/problemes-lies-presidence-cepmb-accentuent-necessite-suspendre-mise-en-oeuvre-lignes-directrices-provisoires-revisees\/","name":"Les probl\u00e8mes li\u00e9s \u00e0 la pr\u00e9sidence du CEPMB accentuent la n\u00e9cessit\u00e9 de suspendre la mise en \u0153uvre des Lignes directrices provisoires r\u00e9vis\u00e9es - Innovative Medicines Canada","isPartOf":{"@id":"https:\/\/innovativemedicines.ca\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/problemes-lies-presidence-cepmb-accentuent-necessite-suspendre-mise-en-oeuvre-lignes-directrices-provisoires-revisees\/#primaryimage"},"image":{"@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/problemes-lies-presidence-cepmb-accentuent-necessite-suspendre-mise-en-oeuvre-lignes-directrices-provisoires-revisees\/#primaryimage"},"thumbnailUrl":"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2022\/12\/iStock-108272690-scaled.jpg","datePublished":"2022-12-15T15:46:12+00:00","dateModified":"2022-12-15T15:47:44+00:00","breadcrumb":{"@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/problemes-lies-presidence-cepmb-accentuent-necessite-suspendre-mise-en-oeuvre-lignes-directrices-provisoires-revisees\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/problemes-lies-presidence-cepmb-accentuent-necessite-suspendre-mise-en-oeuvre-lignes-directrices-provisoires-revisees\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/problemes-lies-presidence-cepmb-accentuent-necessite-suspendre-mise-en-oeuvre-lignes-directrices-provisoires-revisees\/#primaryimage","url":"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2022\/12\/iStock-108272690-scaled.jpg","contentUrl":"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2022\/12\/iStock-108272690-scaled.jpg","width":1980,"height":1320},{"@type":"BreadcrumbList","@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/problemes-lies-presidence-cepmb-accentuent-necessite-suspendre-mise-en-oeuvre-lignes-directrices-provisoires-revisees\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/innovativemedicines.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Actualit\u00e9s","item":"https:\/\/innovativemedicines.ca\/fr\/actualites\/"},{"@type":"ListItem","position":3,"name":"Actualit\u00e9s","item":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/"},{"@type":"ListItem","position":4,"name":"Les probl\u00e8mes li\u00e9s \u00e0 la pr\u00e9sidence du CEPMB accentuent la n\u00e9cessit\u00e9 de suspendre la mise en \u0153uvre des Lignes directrices provisoires r\u00e9vis\u00e9es"}]},{"@type":"WebSite","@id":"https:\/\/innovativemedicines.ca\/fr\/#website","url":"https:\/\/innovativemedicines.ca\/fr\/","name":"Innovative Medicines Canada","description":"Transforming Canadians\u2019 lives","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/innovativemedicines.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/news\/15102","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/types\/news"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/media\/15104"}],"wp:attachment":[{"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/media?parent=15102"}],"wp:term":[{"taxonomy":"topic","embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/topic?post=15102"},{"taxonomy":"team-member-id","embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/team-member-id?post=15102"},{"taxonomy":"news-category","embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/news-category?post=15102"},{"taxonomy":"news-tag","embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/news-tag?post=15102"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}